CURR THER RES CLIN E
ISSN:0011-393X E-ISSN:1879-0313 出版商:Elsevier 国家:UNITED STATES 周期:Bimonthly
| 收录情况 | h-index:34 CiteScore:2.50 |
We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings| as well as in-depth review articles on specific therapies or disease states| and applied health delivery or pharmacoeconomics. CTR encourages and supports the submission of manuscripts describing: • Interventions designed to understand or improve human health| disease treatment or disease prevention; • Studies that focus on problems that are uncommon in resource-rich countries; • Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing); • Republication of articles previously published in non-English journals (eg| evidence-based guidelines) which could be useful if translated into English; • Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.
数据整理自公开网络的投稿反馈,仅供参考。